Skip to main content

Advertisement

Log in

The potential of metabolomics in assessing global compositional changes resulting from the application of CRISPR/Cas9 technologies

  • Research
  • Published:
Transgenic Research Aims and scope Submit manuscript

Abstract

Exhaustive analysis of genetically modified crops over multiple decades has increased societal confidence in the technology. New Plant Breeding Techniques are now emerging with improved precision and the ability to generate products containing no foreign DNA and mimic/replicate conventionally bred varieties. In the present study, metabolomic analysis was used to compare (i) tobacco genotypes with and without the CRISPR associated protein 9 (Cas9), (ii) tobacco lines with the edited and non-edited DE-ETIOLATED-1 gene without phenotype and (iii) leaf and fruit tissue from stable non-edited tomato progeny with and without the Cas9. In all cases, multivariate analysis based on the difference test using LC-HRMS/MS and GC–MS data indicated no significant difference in their metabolomes. The variations in metabolome composition that were evident could be associated with the processes of tissue culture regeneration and/or transformation (e.g. interaction with Agrobacterium). Metabolites responsible for the variance included quantitative changes of abundant, well characterised metabolites such as phenolics (e.g. chlorogenic acid) and several common sugars such as fructose. This study provides fundamental data on the characterisation of gene edited crops, that are important for the evaluation of the technology and its assessment. The approach also suggests that metabolomics could contribute to routine product-based analysis of crops/foods generated from New Plant Breeding approaches.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Data availability

Unprocessed data can be accessed at https://data.mendeley.com/drafts/djd85rr6z9.

Abbreviations

ANOVA:

Analysis of variance

Cas9:

CRISPR associated protein 9

GC–MS:

Gas chromatography mass spectrometry

LC-HRMS:

Liquid chromatography high resolution mass spectrometry

PC:

Principal component

PCA:

Principal component analysis

PLS:

Partial least square

RSD:

Relative standard deviation

TCA:

Tricarboxylic acid

UPLC-PDA:

Ultra performance liquid chromatography-photodiode array detector

References

Download references

Acknowledgements

The authors thank Chris Gerrish and Kit Liew for excellent technical assistance.

Funding

This work was funded by European Union Funding for Research and Innovation “Horizon 2020—NEWCOTIANA—Project No. 760331” and in part by Biotechnology and Biological Sciences Research Council OPTICAR Project BB/P001742/1. 

Author information

Authors and Affiliations

Authors

Contributions

PDF secured funding. MN, JA and ER designed constructs and created the edited plants. MN, GE, JA, MD and PDF designed the experiment. MD cultivated the plants, performed metabolite analysis and analysed the data. MD, JA, GE and PDF wrote the manuscript. All authors reviewed the manuscript.

Corresponding author

Correspondence to Paul D. Fraser.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 396 kb)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Drapal, M., Enfissi, E.M.A., Almeida, J. et al. The potential of metabolomics in assessing global compositional changes resulting from the application of CRISPR/Cas9 technologies. Transgenic Res 32, 265–278 (2023). https://doi.org/10.1007/s11248-023-00347-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11248-023-00347-9

Keywords

Navigation